From: Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
 | Univariable | Stepwise multivariable | ||
---|---|---|---|---|
 | hazard ratio (95 % CI) | p | hazard ratio (95 % CI) | p |
SOFA score at t0MCS | 1.16 (0.95–1.4) | .14 | - | - |
Cardiac arrest before MCS | 2.35 (0.79–7.03) | .13 | - | - |
RBC transfusion by day on MCS | 1.91 (1.17–3.12) | .01 | - | - |
RRT during ICU stay | 2.13 (0.74–6.14) | .16 | - | - |
SAPS II score at ICU admission | 1.04 (1.01–1.07) | .01 | 1.04 (1.01–1.07) | 0.008 |
Vasoactive-inotropic score before Impella | 1.00 (0.998–1.01) | .18 | 1.01 (1.00–1.02) | .035 |
Post-AMI cardiogenic shock | 3.06 (1.02–9.16) | .05 | 4.14 (1.20–14.25) | .024 |
Cardiogenic shock from dilated cardiomyopathy | 0.57 (0.16–2.06) | .40 | Not included |  |
Postcardiotomy cardiogenic shock | 0.32 (0.04–2.44) | .27 | Not included |  |
Cardiogenic shock from other etiologies | 0.61 (0.08–4.63) | .63 | Not included |  |